09 October 2025
09 October 2025
The approval was granted based on data from the Phase III C-POST study.
Marks is now the second high-ranking former FDA employee Lilly has snapped up in the last month.
The growing strength of China’s drug pipelines has gone hand-in-hand with a steep uptick in big pharma licensing deals.
The machines will stock commonly used drugs such as antibiotics, inhalers, and blood pressure medications.
The Phase III trials are aimed at assessing the therapy for treating gout and tophaceous gout.
Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
